CN Patent

CN110251476B — 一种恩曲他滨替诺福韦药物组合物

Assigned to Haisike Pharmaceutical Meishan Co ltd · Expires 2022-08-09 · 4y expired

What this patent protects

本发明提供一种稳定的恩曲他滨替诺福韦药物组合物。本发明制备的药物组合物能够有效的控制有效成分在制备、存储过程中降解，提高药物物理和化学稳定性。本发明还涉及所述药物组合物的制备方法及其用途。

USPTO Abstract

本发明提供一种稳定的恩曲他滨替诺福韦药物组合物。本发明制备的药物组合物能够有效的控制有效成分在制备、存储过程中降解，提高药物物理和化学稳定性。本发明还涉及所述药物组合物的制备方法及其用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN110251476B
Jurisdiction
CN
Classification
—
Expires
2022-08-09
Drug substance claim
No
Drug product claim
No
Assignee
Haisike Pharmaceutical Meishan Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.